FOSTER CITY, Calif. (AP) — FOSTER CITY, Calif. (AP) — Gilead Sciences Inc. (GILD) on Thursday reported second-quarter net income of $1.96 billion.
On a per-share basis, the Foster City, California-based company said it had net income of $1.56. Earnings, adjusted for one-time gains and costs, came to $2.01 per share.
The results surpassed Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $1.95 per share.
The HIV and hepatitis C drugmaker posted revenue of $7.08 billion in the period, also topping Street forecasts. Eight analysts surveyed by Zacks expected $6.95 billion.
Gilead expects full-year earnings in the range of $7.95 to $8.25 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GILD at https://www.zacks.com/ap/GILD
/AI%20(artificial%20intelligence)/AI%20engineer%20working%20on%20laptop%20by%20ART%20STOCK%20CREATIVE%20via%20Shutterstock.jpg)
/Semiconductor%20by%20Gorodenkoff%20via%20Shutterstock.jpg)
